Editorial: Oncogenic PI3KT/Akt/mTOR pathway alterations, ROS homeostasis, targeted cancer therapy and drug resistance
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-02-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2024.1372376/full |
| _version_ | 1797305198850342912 |
|---|---|
| author | Rozangela C. Pedrosa Karina B. Felipe Danilo Wilhelm Filho |
| author_facet | Rozangela C. Pedrosa Karina B. Felipe Danilo Wilhelm Filho |
| author_sort | Rozangela C. Pedrosa |
| collection | DOAJ |
| first_indexed | 2024-03-08T00:22:14Z |
| format | Article |
| id | doaj.art-b42a7aea0f9d4489af80dea015456879 |
| institution | Directory Open Access Journal |
| issn | 2234-943X |
| language | English |
| last_indexed | 2024-03-08T00:22:14Z |
| publishDate | 2024-02-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Oncology |
| spelling | doaj.art-b42a7aea0f9d4489af80dea0154568792024-02-16T05:00:48ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2024-02-011410.3389/fonc.2024.13723761372376Editorial: Oncogenic PI3KT/Akt/mTOR pathway alterations, ROS homeostasis, targeted cancer therapy and drug resistanceRozangela C. Pedrosa0Karina B. Felipe1Danilo Wilhelm Filho2Laboaratory of Experimental Biochemistry, Department of Ecology and Zoology, Federal University of Santa Catarina, Florianopolis, Santa Catarina, BrazilLaboratory of Physiology and Cell Signaling, Department of Clinical Analyses, Federal University of Parana, Curitiba, Parana, BrazilLaboaratory of Experimental Biochemistry, Department of Ecology and Zoology, Federal University of Santa Catarina, Florianopolis, Santa Catarina, Brazilhttps://www.frontiersin.org/articles/10.3389/fonc.2024.1372376/fullcancerPI3KT/Akt/mTOR pathwaycancer therapydrug resistanceapoptosis |
| spellingShingle | Rozangela C. Pedrosa Karina B. Felipe Danilo Wilhelm Filho Editorial: Oncogenic PI3KT/Akt/mTOR pathway alterations, ROS homeostasis, targeted cancer therapy and drug resistance Frontiers in Oncology cancer PI3KT/Akt/mTOR pathway cancer therapy drug resistance apoptosis |
| title | Editorial: Oncogenic PI3KT/Akt/mTOR pathway alterations, ROS homeostasis, targeted cancer therapy and drug resistance |
| title_full | Editorial: Oncogenic PI3KT/Akt/mTOR pathway alterations, ROS homeostasis, targeted cancer therapy and drug resistance |
| title_fullStr | Editorial: Oncogenic PI3KT/Akt/mTOR pathway alterations, ROS homeostasis, targeted cancer therapy and drug resistance |
| title_full_unstemmed | Editorial: Oncogenic PI3KT/Akt/mTOR pathway alterations, ROS homeostasis, targeted cancer therapy and drug resistance |
| title_short | Editorial: Oncogenic PI3KT/Akt/mTOR pathway alterations, ROS homeostasis, targeted cancer therapy and drug resistance |
| title_sort | editorial oncogenic pi3kt akt mtor pathway alterations ros homeostasis targeted cancer therapy and drug resistance |
| topic | cancer PI3KT/Akt/mTOR pathway cancer therapy drug resistance apoptosis |
| url | https://www.frontiersin.org/articles/10.3389/fonc.2024.1372376/full |
| work_keys_str_mv | AT rozangelacpedrosa editorialoncogenicpi3ktaktmtorpathwayalterationsroshomeostasistargetedcancertherapyanddrugresistance AT karinabfelipe editorialoncogenicpi3ktaktmtorpathwayalterationsroshomeostasistargetedcancertherapyanddrugresistance AT danilowilhelmfilho editorialoncogenicpi3ktaktmtorpathwayalterationsroshomeostasistargetedcancertherapyanddrugresistance |